175. Clindamycin versus linezolid for Group A Streptococcal bloodstream infections?: A comparative effectiveness study of adjunctive antitoxin therapy at 137 US Hospitals

BACKGROUND: Adjunctive clindamycin has survival benefit in invasive Group A streptococcus (GAS) infections. Like clindamycin, linezolid also leads to decreased toxin and virulence factor production. However, rising clindamycin resistance among GAS isolates and inadequate clinical data on linezolid b...

Descripción completa

Detalles Bibliográficos
Autores principales: Babiker, Ahmed, Warner, Sarah, Li, Xioabai, Walker, Morgan, Lawandi, Alexander, Kadri, Sameer S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677800/
http://dx.doi.org/10.1093/ofid/ofad500.248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677800/
http://dx.doi.org/10.1093/ofid/ofad500.248

Ejemplares similares